|Individualization of care|
|Rate or rhythm control||
|Pharmacological rhythm control
|Nonpharmacological approaches||Modifiable risk factors: hypertension, diabetes mellitus, sleep apnea, obesity, tobacco use, alcohol consumption|
|Catheter ablation||Favouring catheter ablation in a subset of patients
|Device therapy||Indications for ICD and CRT do not differ for HF patients with or without AF
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Early rhythm control therapy in patients with atrial fibrillation and heart failure.Circulation. 2021; 144: 845-858
- Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial.Circulation. 2021; 143: 1377-1390
- Catheter ablation for atrial fibrillation with heart failure.N Engl J Med. 2018; 378: 417-427
- Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: results from the RAFT-AF trial..Circulation. 2022; 378 (Accessed November 25, 2021.)https://doi.org/10.1161/CIRCULATIONAHA.121.057095
- AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.Eur Heart J. 2021; 42: 4731-4739
See page 843 for disclosure information.